Last reviewed · How we verify

Triamcinolone Acetonide/5-fluorouracil mixture

University of Washington · Phase 3 active Small molecule

Triamcinolone Acetonide is a corticosteroid that reduces inflammation, while 5-fluorouracil is an antimetabolite that interferes with DNA synthesis, making cancer cells more susceptible to death.

Triamcinolone Acetonide is a corticosteroid that reduces inflammation, while 5-fluorouracil is an antimetabolite that interferes with DNA synthesis, making cancer cells more susceptible to death. Used for Actinic keratosis, Seborrheic keratosis.

At a glance

Generic nameTriamcinolone Acetonide/5-fluorouracil mixture
SponsorUniversity of Washington
Drug classCorticosteroid/antimetabolite
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

Triamcinolone Acetonide works by inhibiting the production of inflammatory mediators, which reduces swelling and pain. 5-fluorouracil, on the other hand, is a thymidylate synthase inhibitor that disrupts DNA synthesis, leading to cell death in rapidly dividing cancer cells.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: